468 related articles for article (PubMed ID: 6398598)
1. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
3. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
[TBL] [Abstract][Full Text] [Related]
4. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
5. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
Brett SJ; Draper P; Payne SN; Rees RJ
Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
[TBL] [Abstract][Full Text] [Related]
6. Defective monocyte chemotaxis in active lepromatous leprosy.
Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
9. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
Chujor CS; Bernheimer H; Levis WR; Schwerer B
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
[TBL] [Abstract][Full Text] [Related]
10. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
12. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
13. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy.
Hussain R; Jamil S; Kifayet A; Firdausi F; Dockrell HM; Lucas S; Hasan R
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):491-502. PubMed ID: 2205684
[TBL] [Abstract][Full Text] [Related]
16. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial carbohydrate antigens for serological testing of patients with leprosy.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Brennan PJ; Fried P
J Infect Dis; 1987 Nov; 156(5):763-9. PubMed ID: 3116103
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibodies to phenolic glycolipid by ELISA in leprosy patients.
Lal H; Jain VK; Mittal RA; Chaudhary SD; Saini V
Indian J Lepr; 1993; 65(1):95-9. PubMed ID: 8463728
[TBL] [Abstract][Full Text] [Related]
19. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
[TBL] [Abstract][Full Text] [Related]
20. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
